AKT1 and central nervous system cancer: Both AKT and JNK inhibition blocked EDN‐induced glioma cell migration (Hsieh et al, 2014), and AKT inhibition prevented EDNRA‐mediated migration of hepatocellular carcinoma cells (Cong et al, 2016).